Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 75 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8822681

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  2. US 8822700

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  3. US 8816077

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  4. US 8815866

    Aminopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  5. US 8816046

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  6. US 8815951

    Inhibitors of epoxide hydrolases for the treatment of inflammation

    The Regents of the University of California · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  7. US 8815928

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  8. US 8809335

    Pyrazolopyrimidine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  9. US 8809347

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  10. US 8809264

    Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  11. US 8809377

    Deubiquitinase inhibitors and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  12. US 8809364

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  13. US 8802695

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  14. US 8802733

    Aldehyde dehydrogenase inhibitors as novel depigmenting agents

    The Board of Regents of the University of Texas System · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  15. US 8796008

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  16. US 8796270

    N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

    GILEAD CONNECTICUT, INC. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  17. US 8796259

    N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  18. US 8790652

    Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis

    VACCINEX, INC. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted
  19. US 8791116

    Myosin light chain kinase inhibitor compounds, compositions and related methods of use

    Northwestern University · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted
  20. US 8785444

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  21. US 8785429

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  22. US 8785377

    Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  23. US 8785487

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  24. US 8779001

    Stat3 inhibitors

    The United States of America Dept. of Health and Human Services (DHHS) · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted